期刊文献+

晚期NSCLC三维适形放疗肺低剂量-体积与放射性肺损伤关系初探 被引量:4

The Correlation between Low Dose-Volume and Radiation-Induced Lung Injury with Three-Dimensional Conformal Radiation Therapy in Advanced Non-Small-Cell Lung Cancer
下载PDF
导出
摘要 目的:探讨非小细胞肺癌三维适形放疗肺低剂量-体积与放射性肺损伤的相关性。方法:采用三维适形后程加速超分割放射治疗经病理或细胞学证实的非小细胞肺癌患者46例。男性39例,女性7例。Ⅲa期6例,Ⅲb期18例,Ⅳ期22例。鳞癌22例,腺癌24例。初治37例、术后复发9例。单纯放疗8例,放化综合治疗38例。放疗剂量60Gy-79Gy,中位值70Gy。60Gy-69Gy 10例,≥70Gy 36例。剂量-体积(Vx)通过计划系统DVH图计算获得。肺损伤的评估根据CTC3.0标准评价。化疗方案采用紫杉类+铂类一线方案。结果:(1)V5为37.4%-80%,中位值62.O%;V10为27%-66%,中位值43.1%;V20为17%-39%,中位值29.8%;V30为9%-30%,中位21.1%。(2)急性肺损伤:Ⅰ级12例(27%),Ⅱ级18例(40%),Ⅲ级4例(9%),无Ⅳ级急性损伤。晚期肺损伤:Ⅰ级29例(71%),Ⅱ级5例(12%),无Ⅲ级及以上级晚期损伤。(3)V5、V10、V20、V30与大于Ⅱ级的急性放射性肺炎均具有显著相关性。v5、V10还与大于Ⅰ级的急性肺炎有显著相关性。(4)V5、V10与大于Ⅰ级的晚期肺损伤有显著相关性。V5、V10、V20、V30与大于Ⅱ级的晚期肺损伤无显著相关性。(5)在Vx的分层分析中,V5、V10、V20、V30分别大于62%、43%、30%、22%时,大于Ⅱ级急性放射性肺炎发生率显著增高。V20、V30分别大于30%、22%时,发生大于Ⅱ级的晚期肺损伤的几率有统计学差异。(6)性别、年龄、病理、临床分期、处方剂量、GTV体积、PTV体积与各级放射性肺损伤无显著相关性。结论:低剂量一体积参数v5、V10与V20、V30一样,均是Ⅱ级急性放射性肺损伤有效的预测因素,V5、V10可能在预测轻度放射性肺损伤中有着独立的优势。 Objective: To analyze the correlation between low dose-volume and radiation-induced lung injury in patients accepted three-dimensional conformal radiation therapy (3-DCRT) for advanced non-small-cell lung cancer (NSCLC). Methods: 46 NSCLC patients that were diagnosed by histology or cytology were treated with 3-DCRT from Nov. 2006 to Feb. 2008. 8 patients were treated with radiotherapy alone and 38 patients with radiotherapy plus chemotherapy. The median radiation dose of 70Gy (range 60Gy -79Gy) was delivered by late-course accelerated hyperfractionated radiotherapy (LAHRT). 10 patients received dose of 60Gy - 69Gy,36 received dose of more than 70Gy. The value of dose - volume was calculated by the DVH system. The radiation - induced lung injury was evaluated according to Common Toxicity Criteria 3.0 (CTC 3.0) Results: The range of VS, V10, V20, V30 was 37.4% - 80%, 27% - 66%, 17% - 39%, 9% - 30% respectively, and the median value was 62.0%, 43.1%, 29.8%, 21.1% respectively. The oeeurrenee of grade Ⅰ ,Ⅱ, Ⅲ acute radiation - induced lung injury was 12(27% ), 18(40% ), 4(9% ) respeetively. The oeeurrenee of grade Ⅰ , Ⅱ ehrunie radiation-induced lung injury was 29(71% ), 5( 12% )respectively. V5,V10, V20 ,V30 were all significantly correlated with aeute radiation-induced lung injury over grade Ⅱ. Low dose-volume (V5 ,V10) were significantly correlated with acute radiation-induced lung injury over grade Ⅰ. V5, V10 were significantly correlated with chronic radiation-induced lung injury over grade Ⅰ. The frequency of acute radiationinduced lung injury over grade Ⅱ increased significantly when V5,V10,V20,V30 were more than 62% ,43% ,30% ,22%, respectively. And when V20,V30 were more than 30% ,22%, the probability of chronic radiation-induced lung injury over grade Ⅱ increased significantly. Conclusion: The low dose-volume V5, V10 are the same as V20,V30 which are effective indicators for radiation-induced lung injury. The lower dose-volume V5 ,V10 may be superior to V20 ,V30 in predicting the lower grade radiation-induced lung injury.
出处 《肿瘤预防与治疗》 2009年第3期261-264,共4页 Journal of Cancer Control And Treatment
基金 贵州省科技厅基金资助项目(E2008 -10) 贵州省科技厅科技攻关项目(E2007 -16 )
关键词 非小细胞肺癌(NSCLC) 三维适形放疗(3-DCRT) 低剂量-体积/V5 V10 放射性肺损伤 Non-Small-Cell Lung Cancer Three-Dimensional Conformal Radiation Therapy Low Dose-Volume (V5, V10) Radiation-Induced Lung Injury
  • 相关文献

参考文献10

  • 1J. Bradley, M. Graham, K. winter, et al. Toxicity and outcome results of RTOG 9311: A phase Ⅰ-Ⅱ Ⅱ dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-eel lung carcinoma[J]. Int J Radiat Oncol Biol Phys,2005,61 (2) :318-328.
  • 2Tsujino K,Hirota S,Endo M ,et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer[ J]. Int J Radiat Oncol Biol Phys, 2003,55(1) :110-115.
  • 3Herenando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer[J]. Int J Radiat Oncol Biol Phys ,2001,51 (3) :650-659.
  • 4Piotrowski T, Matecka-Nowak M , Milecki P,et al. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma,2005,52( 1 ) :56-62.
  • 5John M. Sehallenkamp, Robert C. Miller, Debra H. Brinkmann, et al. Incidence of radiation pneumonitis after thoracic irradiation : dose-volume correlates[J]. Int J Radiation Oncology Biol Phys, 2007,67(2) :410-416.
  • 6Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study[ J]. J Radiat Oncol Biol Phys ,2005,63 ( 3 ) :672-682.
  • 7Gopal R,Tucker SL, Ritsuko Komaki, et al. The relationship between local dose and loss of function for irradiated lung[J]. J Radiat Oncol Biol Phys ,2003,56 : 106-113.
  • 8Wang S, Liao Z, Wei X, et al. Analysis of clinical an dosimetric factors associated with treatment-related pneumonitis(TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy(3D-CRT) [J]. Int J Radiat Oncol Biol Phys,2006,66 (5): 1399-1407.
  • 9Emami B,Graham GV. Lung[M]. In:Perez CA,Brady DW,editors. Principles abd practice of radiation oncology. 3rd ed. Philadephia: Lippincott-Raven, 1997 : 1181 - 1120.
  • 10Schild SE, McGinnis WL, David Graham, et al. Result of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unpresectable non-small-cell lung cancer[ J]. Int J Radiat Oncol Biol Phys,2006,65(4) :1106-1111.

同被引文献50

  • 1FU XL,Huang H,Bentel G,et al.Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V30 and transforming growth factor B[J]. Int J Radiation Oncology Biol Phys,2001 ;50:899-908.
  • 2Katrien DE J,Yvette S,Harm HK,et al.Significance of plasma transforming growth factor βlevels in' radiotherapy fur non-small-cell lung cancer[J].Int J Radiation Oncology Biol Phys.2004;58:1378- 1387.
  • 3CHEN Y, Hyrien O,Williams J,et al.lnterleukin(IL)-1a and lL-6:Applications to the predictive diagnostic testing of radiation pneumonitis [J].Int J Radiation Oncology Biol Phys,2005;62:260-266.
  • 4Nicole BB,Lionel BE,Didier C,ct al.Inereascd IL-6 and TGF-B1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy[J].Int J Radiation Oncology Biol Phys,2004;58(3):758-767.
  • 5Tsujino K,Hirota S,Endo M,et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.Int J Radiat Oncol Biol Phys,2003;55(1): 110-115.
  • 6Piotrowski T, Matecka-Nowak M,Milecki P, et al.Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional con-formal radiotherapy.Neoplasma,2005;52(1):56-62.
  • 7殷蔚伯,李晔雄,王绿化,等.肿瘤放射治疗手册[M].北京:中国协和医科大学出版社,2011:324-330.
  • 8Barriger RB, Forquer JA, Brabham JG, et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy [ J ]. Int J Radiat Oncol Biol Phys, 2012, 82 ( 1 ) : 457-462.
  • 9Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis[ J]. Acta Oncol,2012,51 (8) :975-983.
  • 10Giroux Leprieur E, Fernandez D, Chatellier G, et al. Non- small cell lung cancer: risk factors of radiation pneumonitis [ J ]. Cancer Radiother, 2012,16 (4) : 257-262.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部